Primary resistance (PR) of mycobacterium tuberculosis (MBT) to antimicrobial drugs (AMBD) in patients (P) with destructive pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004
The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis Year: 2007
Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy Source: Eur Respir J 2005; 26: Suppl. 49, 192s Year: 2005
Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR) Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB) Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Accompanying therapy of patients with extensive drug-resistant (xdr) lung tuberculosis Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF) Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011
Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients Source: Eur Respir J 2003; 22: Suppl. 45, 521s Year: 2003
Primary multidrug resistance (PMDR) of mycobacterium tuberculosis (MBT) to antimycobacterial drugs (AMBTD) in the patients with destructive TB. Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis Year: 2008
Individualized treatment regimens with second line anti-TB drugs (SLD) compared to first line anti-TB drug (FLD) only in new pulmonary TB patients, culture confirmed with full sensibility at drug sensibility test (DST) Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011
Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR) Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004
Long term plasma rifampicin (R) concentrations in AIDS patients with tuberculosis (TB) under HAART therapy Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
The efficiency of the treatment of the patients with culture-positive pulmonary tuberculosis (CPPTB) in Gdannsk, Poland in 1995 and 2000 Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005
Disease severity for enrollment criteria of patients with idiopathic pulmonary fibrosis (IPF) in clinical trial: evaluation of time to first episode of acute exacerbation (TTA) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
The use of phon resonant therapy (PRT) in treatment of patients with pulmonary tuberculosis, combined with infections, caused by chlamydia (C) and mycoplasma (M) Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Bio-Chip (BCh) technology for diagnostics of multidrug resistance (DR) of mycobacterium tuberculosis (MBT) from patients with disseminated tuberculosis (DT) Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD) Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007